The weekly litigation news digest is live. Subscribe now

IP Verse

Combination Anti Cancer Therapy With An Iap Antagonist And An Anti Pd-1 Molecule - EP3728313

The patent EP3728313 was granted to Debiopharm on Oct 25, 2023. The application was filed on Dec 21, 2018 under application number EP18829861A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3728313

DEBIOPHARM
Application Number
EP18829861A
Filing Date
Dec 21, 2018
Status
Granted And Under Opposition
Jun 30, 2023
Publication Date
Oct 25, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
KRAUS & LEDERER PARTGMBBApr 30, 2024ELKINGTON AND FIFEADMISSIBLE
KRAUS & LEDERER PARTGMBBApr 30, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2016054555
DESCRIPTIONWO2017143449
DESCRIPTIONWO2018195321
OPPOSITIONWO2016009017
OPPOSITIONWO2016054555

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents